Press Releases

October 7, 2008

Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics

Seahorse Bioscience today announced the release of the first ever analytical instrument for the kinetic measurement of mitochondrial oxygen consumption and cytoplasmic glycolysis in cells in a 96 well microplate.

Read More

July 18, 2008

Seahorse Bioscience Receives Poster Award from The European Association for the Study of Obesity

Seahorse Bioscience, Inc., leaders in real-time measurement of cellular bioenergetics announced today the receipt of The European Association for the Study of Obesity (EASO) poster award at the 16th European Congress on Obesity (ECO 2008) May 14-17, 2008 in Geneva, Switzerland.

Read More

May 22, 2008

Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market

Seahorse Bioscience, leaders in real-time measurement of cellular bioenergetics, announced today that Primetech Corporation will become the exclusive supplier of Seahorse XF instruments and consumables in Japan.

Read More

August 10, 2007

Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan To Board Of Directors

Seahorse Bioscience, the leading provider of tools for real-time measurement of cellular bioenergetics in microplates, announced today that former Molecular Devices executive Joseph Keegan has been appointed to the company’s Board of Directors. In this position, Keegan will apply his successful business experience in the life sciences industry to accelerate the growth of Seahorse Bioscience’s novel technology for profiling cell metabolism.

Read More